These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11276322)

  • 1. Effect of mu-opiate receptor agonist tetrapeptide A10 on DNA synthesis and protein content in the myocardium of albino rats.
    Mel'nikova NP; Timoshin SS; Murzina NB; Sazonova EN; Kuznetsov AV; Yarova EP
    Bull Exp Biol Med; 2000 Dec; 130(12):1206-8. PubMed ID: 11276322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of mu-opioid receptor agonist tetrapeptide A10 on the DNA synthesis in the myocardium and liver of albino rats during early stages of postnatal ontogenesis].
    Goncharova EN; Mel'nikova NP; Iatsenko TV; Timoshin SS; Iarova EP
    Biull Eksp Biol Med; 1997 Feb; 123(2):212-5. PubMed ID: 9280499
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
    Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modulating effect of mu-opioid receptor ligands on adrenergic mechanism of stressor heart damage pathogenesis].
    Lishmanov IuB; Naryzhnaia NV; Revinskaia IuG; Maslov LN
    Biull Eksp Biol Med; 1998 Nov; 126(11):510-2. PubMed ID: 9883355
    [No Abstract]   [Full Text] [Related]  

  • 5. [Processes of protein biosynthesis in cardiac muscle and cardioprotective effect of mu-opiate receptor ligands in immobilization stress].
    Naryzhnaia NV; Maslov LN; Lishmanov IuB
    Vopr Med Khim; 2000; 46(2):127-34. PubMed ID: 10885032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphofunctional manifestations of cardioprotective effect of mu-opioid receptor stimulation in stress].
    Maslov LN; Revinskaia IuG; Ryzhov AI; Naryzhnaia NV
    Patol Fiziol Eksp Ter; 2001; (2):8-12. PubMed ID: 11550368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the arginine-containing mu,delta-opiate receptor agonist sedatin on DNA synthesis in the epithelium of the gastric fundus in albino rats.
    Fleishman MY; Kuznetsov AV; Deigin VI; Timoshin SS
    Bull Exp Biol Med; 2004 Mar; 137(3):235-7. PubMed ID: 15232627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
    Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
    Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation of mu-opioid receptors and cardiomyocyte resistance to free radical damage].
    Lasukova TV; Rebrova TIu
    Patol Fiziol Eksp Ter; 2001; (2):15-7. PubMed ID: 11550361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of endothelin-1 on DNA synthesis in the myocardium of albino rats during early postnatal ontogeny.
    Sazonova EN; Sazonov OA; Lebed'ko OA; Pikalova VM; Timoshin SS; Rubina AY
    Bull Exp Biol Med; 2000 Dec; 130(12):1144-6. PubMed ID: 11276305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of CNS opioid on autonomic nervous and cardiovascular responses in diet-induced obese rats.
    Barnes MJ; Jen KL; Dunbar JC
    Peptides; 2004 Jan; 25(1):71-9. PubMed ID: 15003358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed effect of the tetrapeptide tyr-D-ala-gly-phe-NH2 on the serotonin content of the synaptosomes of the rabbit brain].
    Uzbekov MG
    Biull Eksp Biol Med; 1983 Feb; 95(2):38-40. PubMed ID: 6824772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.
    Balboni G; Cocco MT; Salvadori S; Romagnoli R; Sasaki Y; Okada Y; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2005 Aug; 48(17):5608-11. PubMed ID: 16107162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.